The authors summarize current knowledge regarding the roles of post-transcriptional checkpoints in autoimmunity, as evidenced by studies in both hematopoietic and non-hematopoietic cells, and discuss the relevance of these findings for developing new anti-inflammatory therapies.
[Nature Reviews Rheumatology]
